Pfizer Covid 19 (BNT162b2) Vaccine
Dear Medicines and Healthcare Products Regulatory Agency,
The initial authorisation of the Pfizer Covid 19 (BNT162b2) vaccine product was given by Lord James Bethell (the Minister) in his capacity as licensing authority for such.
Please provide me with full details of the information which was provided to the Minister in order for him to proceed and grant such authorisation.
Yours faithfully,
A. I. Clayton
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Experience
Centre Team. We will respond to you as soon as possible.
Please note that we may not respond if your query:
· contains offensive language
· has already been answered in a previous reply to you
· is illegible
· is selling or promoting a product
· is for information only
Kind regards
MHRA Customer Services Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
[1][IMG][2]Medicines and Healthcare products Regulatory Agency
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres' Privacy Notices: MHRA,
CPRD and NIBSC
DISCLAIMER This email and any files transmitted with it are confidential.
If you are not the intended recipient, any reading, printing, storage,
disclosure, copying or any other action taken in respect of this email is
prohibited and may be unlawful. If you are not the intended recipient,
please notify the sender immediately by using the reply function and then
permanently delete what you have received. Incoming and outgoing email
messages are routinely monitored for compliance with the Department of
Health's policy on the use of electronic communications. For more
information on the Department of Health's email policy, click
[3]DHTermsAndConditions
References
Visible links
1. http://www.gov.uk/mhra
2. http://www.gov.uk/mhra
3. https://www.gov.uk/help/terms-conditions
Our Ref: FOI 24/189
Dear A I Clayton,
RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
Thank you for your enquiry which we received on 26th February 2024.
I confirm that your request is now being handled under the Freedom of Information Act 2000 and you should receive a reply within 20 working days from our date of receipt.
If you need to contact us again about this request, please quote the reference number above.
Please be aware that we publish FOIs replies and these are redacted and are located on our website at the following link below.
https://www.gov.uk/government/collection...
Kind Regards,
MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf,
London E14 4PU
Dear A I Clayton,
We are writing to advise that we are working to finalise the response to your request, and we will not be able to meet the statutory 20 day time frame for response on this occasion; however, we are seeking to do this within the next 7 working days and will respond to you at that time. We apologise for this delay and any inconvenience caused.
Kind Regards,
MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf,
London E14 4PU
Dear A I Clayton
Re: FOI 24/189
Please find attached the response and disclosure documents for your
request FOI 24/189. Please accept our apologies for the delay in issuing
this response to you.
Yours sincerely,
MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now